Delivery Order SPE2DX22D0129-SPE2D826F0CBB
- Not listed
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $70,055.60 to AmerisourceBergen Drug Corp on December 15, 2025, with an ultimate completion date of December 16, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitive award to the prime contractor under its existing indefinite delivery contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform work...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $345,601.20 to AmerisourceBergen Drug Corp on November 3, 2025, with an ultimate completion date of November 4, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the pharmaceutical distributor for medical supply fulfillment. The contractor's corporate office, located in Conshohocken, Pennsylvania, will serve as the place of performance....
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order contract worth $700,206.02 to AmerisourceBergen Drug Corp on December 16, 2025, with an ultimate completion date of December 17, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitive award to the pharmaceutical distributor for medical supply fulfillment. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its Corporate...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $56,724 to AmerisourceBergen Drug Corp on December 18, 2025, with completion expected by December 19, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the pharmaceutical distributor's corporate office located in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's existing indefinite delivery contract (IDC)...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $6,146.40 to AmerisourceBergen Drug Corp on December 1, 2025, with completion scheduled for December 2, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the pharmaceutical distributor for medical supplies supporting federal healthcare requirements. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $69,936.15 to AmerisourceBergen Drug Corp on December 15, 2025, with ultimate completion by December 16, 2025. This firm fixed-price, non-set-aside contract is a child order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $1 billion through December 2026. The delivery order will be performed at AmerisourceBergen's...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $1,909.80 to AmerisourceBergen Drug Corp on December 4, 2025, with an ultimate completion date of December 5, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the pharmaceutical distributor for medical supply fulfillment. The contract was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $1,699.06 to AmerisourceBergen Drug Corp on December 3, 2025, with an ultimate completion date of December 4, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitive award to the pharmaceutical distributor for medical supplies to support federal healthcare operations. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a...
- The U.S. Defense Logistics Agency's Medical Supply Chain has awarded a delivery order valued at $268,874.70 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This firm fixed-price delivery order, issued on December 1, 2025, with an ultimate completion date of December 2, 2025, represents a child order under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award carries no set-aside...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $1,117.55 to AmerisourceBergen Drug Corp on December 15, 2025, with an ultimate completion date of December 16, 2025. This is a firm fixed price delivery order issued under a larger contract vehicle and represents a non-competitive award to the prime contractor. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor...
- SPE2DX22D0129Indefinite Delivery Contract
- SPE2DX22D0129-SPE2D826F0CBBDelivery Order
The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $70,680.00 to AmerisourceBergen Drug Corp on December 8, 2025, with an ultimate completion date of December 9, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitive award to the pharmaceutical distributor for medical supply procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same municipality. This award is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. As a major pharmaceutical distributor, AmerisourceBergen Drug Corp supplies an extensive portfolio of pharmaceutical products and medical supplies to federal customers, including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's federal contract history demonstrates consistent capability in delivering brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains through competitively awarded delivery orders with firm fixed pricing. This particular delivery order contributes to the broader Medical Supply Chain initiative, which supports the distribution of critical medical commodities necessary for military and veteran healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $70.7k | 12/7/25 |